Skip to main content
Clinical Trials/DRKS00021040
DRKS00021040
Recruiting
Not Applicable

Assesment and optimising psychosocial care for persons with Li-Fraumeni syndrome and their relatives as part of the intensified screening and follow-up programme

niversitätsfrauenklinik Heidelberg0 sites100 target enrollmentApril 12, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer predispostionPathogenic TP53 germline variant
Sponsor
niversitätsfrauenklinik Heidelberg
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 12, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
niversitätsfrauenklinik Heidelberg

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of LFS, Li\-Fraumeni\-Like\-Syndrome, pathogenic TP53 germline variant
  • \- Relatives (relative, partner, close person)
  • \- From the age of 18
  • \- German as mother tongue or very good knowledge of German
  • \- Existence of an informed written consent to participate in the study

Exclusion Criteria

  • unclassified variant in the TP 53 germline (VUS), \<18 years, not able to provide written informed consent, missing buisness capability, no sufficeint german language skills, unablility to pariticpate in interviews or answer questionairs, missing informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials